Filter by patients with: All

What is Alemtuzumab?

Category: Prescription Drugs

Most popular types: Lemtrada Campath

false

Alemtuzumab is commonly used as a single agent for the treatment of B-cell chronic lymphocytic leukemia (B-CLL) and multiple sclerosis.

See patients taking Alemtuzumab

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Multiple sclerosis 583 101
Chronic lymphocytic leukemia 18 0
T-cell prolymphocytic leukemia 10 1
Participate in clinical trial 4 2
Bone marrow transplant 1 1

Show all 12 reasons taken

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell
See all 710 patients that have taken Alemtuzumab

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 8
Moderate 23
Mild 36
None 39

Commonly reported side effects and conditions associated with Alemtuzumab

Side effect Patients Percentage
Headaches 17
Fatigue 16
Fever/chills 7
Generalized weakness (asthenia) 5
Hives (urticaria) 5
Nausea 4

Show all 64 reported side effects

Why patients stopped taking Alemtuzumab

Multiple reasons could be selected

Reason Patients Percentage
Course of treatment ended 15
Did not seem to work 3
Other 3
Doctor's advice 1
See all 26 patients who've stopped taking Alemtuzumab

Duration

Stopped taking Alemtuzumab

Duration Patients Percentage
Less than 1 month 17
6 months - 1 year 2
1 - 2 years 4
2 - 5 years 2
5 - 10 years 1
Adherence
Adherence Evaluations Percentage
Always 93
Usually 1
Sometimes 4
Never taken as prescribed 8
Burden
Burden Evaluations Percentage
Very hard to take 13
Somewhat hard to take 21
A little hard to take 25
Not at all hard to take 47
Cost per month
Cost per month Evaluations Percentage
$200+ 1
$100-199 0
$50-99 0
$25-49 0
< $25 48
Not specified 57

What people switch to and from

Patients started taking Alemtuzumab after stopping:

Treatment Patients Percentage
Natalizumab (Tysabri) 22
Dimethyl fumarate (Tecfidera) 14
Fingolimod (Gilenya) 7
Teriflunomide (Aubagio) 6
Glatiramer acetate (Copaxone) 5

Show all 11 treatments patients report switching from

Patients stopped taking Alemtuzumab and switched to:

Treatment Patients Percentage
Ocrelizumab (Ocrevus) 3
Dimethyl fumarate (Tecfidera) 2
Fingolimod (Gilenya) 1
Teriflunomide (Aubagio) 1
Last updated:

4 patient evaluations for Alemtuzumab

Sort by: Most recent

Aug 15, 2016 (Started Sep 21, 2015)

  • Effectiveness
    Moderate (for multiple sclerosis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 50 mg One time
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.

Nov 28, 2015 (Started Sep 21, 2015)

  • Effectiveness
    None (for multiple sclerosis)
  • Side effects
    Mild (fatigue, muscle weakness, headaches, abnormal urine smell, whole body ache)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 50 mg One time
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.

Oct 16, 2015 (Started Sep 21, 2015)

  • Effectiveness
    Can't tell (for multiple sclerosis)
  • Side effects
    Moderate (fatigue, muscle weakness, headaches, abnormal urine smell, whole body ache)
  • Adherence
    Always
  • Burden
    Very hard to take
Dosage: 50 mg One time
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.

Oct 3, 2015 (Started Sep 21, 2015)

  • Effectiveness
    Can't tell (for multiple sclerosis)
  • Side effects
    Moderate (fatigue, muscle weakness, headaches, abnormal urine smell, whole body ache)
  • Adherence
    Always
  • Burden
    Very hard to take
Dosage: 50 mg One time
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.

Sep 29, 2015 (Started Sep 21, 2015)

  • Effectiveness
    Can't tell (for multiple sclerosis)
  • Side effects
    Moderate (fatigue, muscle weakness, headaches, abnormal urine smell, whole body ache)
  • Adherence
    Always
  • Burden
    Very hard to take
Dosage: 50 mg One time
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.

Sep 25, 2015 (Started Sep 21, 2015)

  • Effectiveness
    Can't tell (for multiple sclerosis)
  • Side effects
    Mild (fatigue, muscle weakness, headaches, abnormal urine smell, whole body ache)
  • Adherence
    Always
  • Burden
    Very hard to take
Dosage: 50 mg One time
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
  • 4 helpful marks

Jun 9, 2015 (Started Jul 01, 1900)

  • Effectiveness
    Can't tell (for multiple sclerosis)
  • Side effects
    None
  • Adherence
    Never taken as prescribed
  • Burden
    Not at all hard to take
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
  • 1 helpful mark

Sep 1, 2009 (Started Jan 03, 2007)

  • Effectiveness
    Major (for multiple sclerosis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 30 mg One time
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
  • 0 helpful marks
Last updated:
Showing 3 of 4 patient evaluations for Alemtuzumab